Literature DB >> 9649461

Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes.

G Verstovsek1, A Byrd, M R Frey, N J Petrelli, J D Black.   

Abstract

BACKGROUND & AIMS: Colon cancer cells express reduced levels of protein kinase C (PKC). This study examines the regulation of PKC isozymes in normal colonic epithelium, as a basis for understanding the significance of alterations in this enzyme system in colon carcinogenesis.
METHODS: The expression and localization of PKC isozymes in mouse and rat colonocytes at different developmental stages were determined using a combined morphological and biochemical approach. PKC alpha expression was compared in colonic adenocarcinomas and adjacent normal mucosa by immunoblot analysis.
RESULTS: Mouse and rat colonocytes express PKC alpha, beta II, delta, epsilon, and zeta. Relatively low levels of these isozymes were detected in proliferating cells of the crypt base, predominantly in the cytosolic compartment. Coincident with colonocyte growth arrest/differentiation, PKC isozyme expression markedly increased in both the cytosolic and, more significantly, in the membrane/cytoskeletal fraction. Colonic tumors express reduced levels of PKC alpha, an isozyme that has been implicated in negative control of intestinal cell growth.
CONCLUSIONS: These findings are supportive of a role for certain PKC isozyme(s) in signaling pathways mediating postmitotic events in colonocytes in situ, and suggest that diminished activity of these pathway(s) may contribute to the alterations in growth control/differentiation associated with colonic neoplasia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649461     DOI: 10.1016/s0016-5085(98)70367-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes.

Authors:  J K Roche; C A Martins; R Cosme; R Fayer; R L Guerrant
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction.

Authors:  J Demaude; C Salvador-Cartier; J Fioramonti; L Ferrier; L Bueno
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

3.  Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.

Authors:  Fang Hao; Marybeth A Pysz; Kathryn J Curry; Kristin N Haas; Steven J Seedhouse; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

4.  Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon.

Authors:  C M Doolan; S B Condliffe; B J Harvey
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine.

Authors:  Marguerite S Buzza; Sarah Netzel-Arnett; Terez Shea-Donohue; Aiping Zhao; Chen-Yong Lin; Karin List; Roman Szabo; Alessio Fasano; Thomas H Bugge; Toni M Antalis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

6.  Protein kinase Cgamma in colon cancer cells: expression, Thr514 phosphorylation and sensitivity to butyrate-mediated upregulation as related to the degree of differentiation.

Authors:  Dorota Garczarczyk; Krisztina Szeker; Peter Galfi; Adam Csordas; Johann Hofmann
Journal:  Chem Biol Interact       Date:  2010-02-25       Impact factor: 5.192

7.  Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor.

Authors:  P J Mannon; J M Mele
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

8.  RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.

Authors:  Olga V Leontieva; Yuri Ionov
Journal:  Cell Cycle       Date:  2009-02-22       Impact factor: 4.534

9.  PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.

Authors:  Marybeth A Pysz; Olga V Leontieva; Nicholas W Bateman; Joshua M Uronis; Kathryn J Curry; David W Threadgill; Klaus-Peter Janssen; Sylvie Robine; Anna Velcich; Leonard H Augenlicht; Adrian R Black; Jennifer D Black
Journal:  Exp Cell Res       Date:  2009-02-14       Impact factor: 3.905

10.  Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.

Authors:  K A Benhadji; M Serova; A Ghoul; E Cvitkovic; C Le Tourneau; S M Ogbourne; F Lokiec; F Calvo; P Hammel; S Faivre; E Raymond
Journal:  Br J Cancer       Date:  2008-12-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.